Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Sarcoma × amrubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Sarcoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Breast Neoplasms 1

Interventions

Doxorubicin 31 Ifosfamide 22 pazopanib 17 Gemcitabine 15 Cyclophosphamide 14 Radiotherapy 13 pembrolizumab 11 Filgrastim 10 Docetaxel 10 Vincristine 9 Sirolimus 9 Etoposide 9 Irinotecan 8 Bevacizumab 8 Sorafenib 7 temsirolimus 6 olaratumab 6 eribulin 6 Mesna 6 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Granulocyte Colony-Stimulating Factor 5 tazemetostat 4 etoposide phosphate 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01259375 2017-04-17

ARSARC-PI-0010

University of Utah

Phase 2 Completed

24 enrolled 10 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡